John Kurhanewicz 1
1University of California San Francisco, San Francisco, CA, USA
At diagnosis 1.5T MRI/MRSI has shown the potential to significantly improve the local evaluation of prostate cancer presence and volume and has been shown to have a significant incremental benefit in the prediction of pathological stage when added to clinical nomograms. After therapy, two metabolic biomarkers of effective and ineffective therapy have been identified and are being validated. Studies have also shown that accuracy can be improved by performing MRI/MRSI at higher magnetic field strengths (3T), through the addition of other functional MR techniques, namely diffusion-weighted